Eupolio (sabin inactivated poliovirus vaccine) / Sinovac, Intravacc  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eupolio (sabin inactivated poliovirus vaccine) / Intravacc, Sinovac
NCT04618783: Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization

Completed
N/A
250
RoW
Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses, Three doses of medium-dosage investigational sIPV, vaccinated within one-month interval between doses, Three doses of high-dosage investigational sIPV, vaccinated within one-month interval between doses, Three doses of control wIPV, vaccinated within one-month interval between doses, Three doses of control sIPV, vaccinated within one-month interval between doses
Sinovac Biotech Co., Ltd
Poliomyelitis
12/19
01/20
NCT04989231: An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses

Completed
N/A
450
RoW
Investigational sIPV, Control IPV
Sinovac Biotech Co., Ltd
Poliomyelitis
12/22
12/22
NCT06058429: Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

Active, not recruiting
N/A
233
RoW
no intervention
Sinovac Biotech Co., Ltd, Jiangxi Center for Disease Control and Prevention
Polio
09/23
12/23

Download Options